The Canadian dollar rose to a near three-week high against its U.S. counterpart on Monday, as investors weighed the potential for Canada's economy to escape broad-based U.S. tariffs and a report ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities.

Protecting and conserving our natural heritage, predicting weather and environmental conditions, preventing and managing pollution, promoting clean growth and a sustainable environment for present and ...

President Donald Trump doubled down this week on his plans for an across the board 25% tariff on goods imported from Canada ...

Amycretin could give Novo a buzzy product in a newly competitive obesity market. It works similarly to existing GLP-1 ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

WHAT IT MEANS FOR PATIENTSThe potential for more aggressive price cuts would enable wider access to GLP-1 drugs - the same ...

The price negotiations ... and Otezla. Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S.

After the Centers for Medicare & Medicaid Services announced the selection of 15 additional drugs covered under Medicare Part D for price negotiations – including Novo Nordisk’s (NVO) Ozempic, ...

They commented: 'Omg Katie what's happening to you,' 'Ozempic working its wonders again….' 'From a place of love - I've loved you my entire life … please eat,' 'Who is looking after her?